Items where authors include "Valdez, H."

Article

Cork, M.J. orcid.org/0000-0003-4428-2428, Deleuran, M., Geng, B. et al. (8 more authors) (2025) Long-term safety of abrocitinib in moderate-to-severe atopic dermatitis: integrated analysis by age. The Journal of Allergy and Clinical Immunology: In Practice. ISSN 2213-2198

Cork, M.J. orcid.org/0000-0003-4428-2428, McMichael, A., Teng, J. et al. (6 more authors) (2022) Impact of oral abrocitinib on signs, symptoms and quality of life among adolescents with moderate‐to‐severe atopic dermatitis : an analysis of patient‐reported outcomes. Journal of the European Academy of Dermatology and Venereology, 36 (3). pp. 422-433. ISSN 0926-9959

Simpson, E.L., Sinclair, R., Forman, S. et al. (14 more authors) (2020) Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet, 396 (10246). pp. 255-266. ISSN 0140-6736